#METABOLOMICS WORKBENCH EmilyLette_20210225_014138 DATATRACK_ID:2509 STUDY_ID:ST001721 ANALYSIS_ID:AN002805 PROJECT_ID:PR001103
VERSION             	1
CREATED_ON             	March 15, 2021, 12:03 pm
#PROJECT
PR:PROJECT_TITLE                 	Detecting sex-related changes to the metabolome of a critically endangered
PR:PROJECT_TITLE                 	freshwater crayfish during the mating season
PR:PROJECT_TYPE                  	MS analysis of crustacean haemolymph
PR:PROJECT_SUMMARY               	Captive breeding is a vital tool in the conservation of highly endangered
PR:PROJECT_SUMMARY               	species, as it is for the Margaret River hairy marron, Cherax tenuimanus, from
PR:PROJECT_SUMMARY               	the south west of Australia. A close relative, Cherax cainii, has almost
PR:PROJECT_SUMMARY               	completely displaced C. tenuimanus in the wild and is a successful aquaculture
PR:PROJECT_SUMMARY               	species, whereas C. tenuimanus has performed poorly in captivity. We used
PR:PROJECT_SUMMARY               	untargeted liquid chromatography-mass spectrometry to obtain metabolomic
PR:PROJECT_SUMMARY               	profiles of female and male C. tenuimanus held in controlled aquarium conditions
PR:PROJECT_SUMMARY               	during their reproductive period. Using repeated haemolymph sampling we tracked
PR:PROJECT_SUMMARY               	the metabolomic profiles of animals just prior to and for a period of up to 34
PR:PROJECT_SUMMARY               	days after pairing with a similar sized potential mate. We identified 54
PR:PROJECT_SUMMARY               	reproducible annotated metabolites including amino acids, fatty acids, biogenic
PR:PROJECT_SUMMARY               	amines, purine and pyrimidine metabolites and excretion metabolites.
PR:PROJECT_SUMMARY               	Hierarchical clustering analysis distinguished five metabolite clusters.
PR:PROJECT_SUMMARY               	Principal component-canonical variate analysis clearly distinguished females
PR:PROJECT_SUMMARY               	from males, both unpaired and paired; similar trends in profile changes in both
PR:PROJECT_SUMMARY               	sexes after pairing; and a striking shift in males upon pairing. We discuss
PR:PROJECT_SUMMARY               	three main patterns of metabolomic responses: differentiation between sexes;
PR:PROJECT_SUMMARY               	reactive responses to the disturbance of pairing; and convergent response to the
PR:PROJECT_SUMMARY               	disturbance of pairing for males. Females generally had higher concentrations of
PR:PROJECT_SUMMARY               	metabolites involved in metabolic rate, mobilisation of energy stores and
PR:PROJECT_SUMMARY               	stress. Responses to the disturbance of pairing were also related to elevated
PR:PROJECT_SUMMARY               	stress. Females were mobilising lipid stores to deposit yolk, whereas males had
PR:PROJECT_SUMMARY               	a rapid and strong response to pairing, with shifts in metabolites associated
PR:PROJECT_SUMMARY               	with gonad development and communication, indicating males could complete
PR:PROJECT_SUMMARY               	reproductive readiness only once paired with a female. The metabolomic profiles
PR:PROJECT_SUMMARY               	support a previously proposed potential mechanism for displacement of C.
PR:PROJECT_SUMMARY               	tenuimanus by C. cainii in the wild and identify several biomarkers for testing
PR:PROJECT_SUMMARY               	hypotheses regarding reproductive success using targeted metabolomics.
PR:INSTITUTE                     	Edith Cowan University
PR:DEPARTMENT                    	School of Science
PR:LAST_NAME                     	Lette
PR:FIRST_NAME                    	Emily
PR:ADDRESS                       	270 Joondalup Drive, Joondalup, WA, 6027, Australia
PR:EMAIL                         	e.lette@ecu.edu.au
PR:PHONE                         	+61 8 6304 5513
#STUDY
ST:STUDY_TITLE                   	Detecting sex-related changes to the metabolome of a critically endangered
ST:STUDY_TITLE                   	freshwater crayfish during the mating season
ST:STUDY_TYPE                    	LC-MS analysis of crustacean haemolymph
ST:STUDY_SUMMARY                 	Captive breeding is a vital tool in the conservation of highly endangered
ST:STUDY_SUMMARY                 	species, as it is for the Margaret River hairy marron, Cherax tenuimanus, from
ST:STUDY_SUMMARY                 	the south west of Australia. A close relative, Cherax cainii, has almost
ST:STUDY_SUMMARY                 	completely displaced C. tenuimanus in the wild and is a successful aquaculture
ST:STUDY_SUMMARY                 	species, whereas C. tenuimanus has performed poorly in captivity. We used
ST:STUDY_SUMMARY                 	untargeted liquid chromatography-mass spectrometry to obtain metabolomic
ST:STUDY_SUMMARY                 	profiles of female and male C. tenuimanus held in controlled aquarium conditions
ST:STUDY_SUMMARY                 	during their reproductive period. Using repeated haemolymph sampling we tracked
ST:STUDY_SUMMARY                 	the metabolomic profiles of animals just prior to and for a period of up to 34
ST:STUDY_SUMMARY                 	days after pairing with a similar sized potential mate. We identified 54
ST:STUDY_SUMMARY                 	reproducible annotated metabolites including amino acids, fatty acids, biogenic
ST:STUDY_SUMMARY                 	amines, purine and pyrimidine metabolites and excretion metabolites.
ST:STUDY_SUMMARY                 	Hierarchical clustering analysis distinguished five metabolite clusters.
ST:STUDY_SUMMARY                 	Principal component-canonical variate analysis clearly distinguished females
ST:STUDY_SUMMARY                 	from males, both unpaired and paired; similar trends in profile changes in both
ST:STUDY_SUMMARY                 	sexes after pairing; and a striking shift in males upon pairing. We discuss
ST:STUDY_SUMMARY                 	three main patterns of metabolomic responses: differentiation between sexes;
ST:STUDY_SUMMARY                 	reactive responses to the disturbance of pairing; and convergent response to the
ST:STUDY_SUMMARY                 	disturbance of pairing for males. Females generally had higher concentrations of
ST:STUDY_SUMMARY                 	metabolites involved in metabolic rate, mobilisation of energy stores and
ST:STUDY_SUMMARY                 	stress. Responses to the disturbance of pairing were also related to elevated
ST:STUDY_SUMMARY                 	stress. Females were mobilising lipid stores to deposit yolk, whereas males had
ST:STUDY_SUMMARY                 	a rapid and strong response to pairing, with shifts in metabolites associated
ST:STUDY_SUMMARY                 	with gonad development and communication, indicating males could complete
ST:STUDY_SUMMARY                 	reproductive readiness only once paired with a female. The metabolomic profiles
ST:STUDY_SUMMARY                 	support a previously proposed potential mechanism for displacement of C.
ST:STUDY_SUMMARY                 	tenuimanus by C. cainii in the wild and identify several biomarkers for testing
ST:STUDY_SUMMARY                 	hypotheses regarding reproductive success using targeted metabolomics.
ST:INSTITUTE                     	Edith Cowan University
ST:DEPARTMENT                    	School of Science
ST:LAST_NAME                     	Lette
ST:FIRST_NAME                    	Emily
ST:ADDRESS                       	270 Joondalup Drive, Joondalup, WA, 6027, Australia
ST:EMAIL                         	e.lette@ecu.edu.au
ST:PHONE                         	+61 8 6304 5513
ST:TOTAL_SUBJECTS                	10
ST:NUM_MALES                     	5
ST:NUM_FEMALES                   	5
#SUBJECT
SU:SUBJECT_TYPE                  	Invertebrate
SU:SUBJECT_SPECIES               	Cherax tenuimanus
SU:TAXONOMY_ID                   	99755
SU:WEIGHT_OR_WEIGHT_RANGE        	116g-198g
SU:GENDER                        	Male and female
#FACTORS
#SUBJECT_SAMPLE_FACTORS:         	SUBJECT(optional)[tab]SAMPLE[tab]FACTORS(NAME:VALUE pairs separated by |)[tab]Raw file names and additional sample data
SUBJECT_SAMPLE_FACTORS           	-	QC9	Sex:- | Timepoint:-	RAW_FILE_NAME=Area_QE_2018_Q2_0872_QC_raw_F1_;Area_QE_2018_Q2_0971_QC_raw_F1_
SUBJECT_SAMPLE_FACTORS           	-	QC10	Sex:- | Timepoint:-	RAW_FILE_NAME=Area_QE_2018_Q2_0873_QC_raw_F2_;Area_QE_2018_Q2_0972_QC_raw_F2_
SUBJECT_SAMPLE_FACTORS           	-	FH1_4	Sex:Female | Timepoint:4	RAW_FILE_NAME=Area_QE_2018_Q2_0874_Sample_raw_F3_;Area_QE_2018_Q2_0973_Sample_raw_F3_
SUBJECT_SAMPLE_FACTORS           	-	FH1_2	Sex:Female | Timepoint:2	RAW_FILE_NAME=Area_QE_2018_Q2_0875_Sample_raw_F4_;Area_QE_2018_Q2_0974_Sample_raw_F4_
SUBJECT_SAMPLE_FACTORS           	-	FH1_3	Sex:Female | Timepoint:3	RAW_FILE_NAME=Area_QE_2018_Q2_0876_Sample_raw_F5_;Area_QE_2018_Q2_0975_Sample_raw_F5_
SUBJECT_SAMPLE_FACTORS           	-	FH1_1	Sex:Female | Timepoint:1	RAW_FILE_NAME=Area_QE_2018_Q2_0877_Sample_raw_F6_;Area_QE_2018_Q2_0976_Sample_raw_F6_
SUBJECT_SAMPLE_FACTORS           	-	FH2_1	Sex:Female | Timepoint:1	RAW_FILE_NAME=Area_QE_2018_Q2_0878_Sample_raw_F7_;Area_QE_2018_Q2_0977_Sample_raw_F7_
SUBJECT_SAMPLE_FACTORS           	-	FH2_3	Sex:Female | Timepoint:3	RAW_FILE_NAME=Area_QE_2018_Q2_0879_Sample_raw_F8_;Area_QE_2018_Q2_0978_Sample_raw_F8_
SUBJECT_SAMPLE_FACTORS           	-	FH2_2	Sex:Female | Timepoint:2	RAW_FILE_NAME=Area_QE_2018_Q2_0880_Sample_raw_F9_;Area_QE_2018_Q2_0979_Sample_raw_F9_
SUBJECT_SAMPLE_FACTORS           	-	FH2_4	Sex:Female | Timepoint:4	RAW_FILE_NAME=Area_QE_2018_Q2_0881_Sample_raw_F10_;Area_QE_2018_Q2_0980_Sample_raw_F10_
SUBJECT_SAMPLE_FACTORS           	-	QC11	Sex:- | Timepoint:-	RAW_FILE_NAME=Area_QE_2018_Q2_0882_QC_raw_F11_;Area_QE_2018_Q2_0981_QC_raw_F11_
SUBJECT_SAMPLE_FACTORS           	-	FH3_3	Sex:Female | Timepoint:3	RAW_FILE_NAME=Area_QE_2018_Q2_0883_Sample_raw_F12_;Area_QE_2018_Q2_0982_Sample_raw_F12_
SUBJECT_SAMPLE_FACTORS           	-	FH3_1	Sex:Female | Timepoint:1	RAW_FILE_NAME=Area_QE_2018_Q2_0884_Sample_raw_F13_;Area_QE_2018_Q2_0983_Sample_raw_F13_
SUBJECT_SAMPLE_FACTORS           	-	FH3_2	Sex:Female | Timepoint:2	RAW_FILE_NAME=Area_QE_2018_Q2_0885_Sample_raw_F14_;Area_QE_2018_Q2_0984_Sample_raw_F14_
SUBJECT_SAMPLE_FACTORS           	-	FH3_4	Sex:Female | Timepoint:4	RAW_FILE_NAME=Area_QE_2018_Q2_0886_Sample_raw_F15_;Area_QE_2018_Q2_0985_Sample_raw_F15_
SUBJECT_SAMPLE_FACTORS           	-	FH4_2	Sex:Female | Timepoint:2	RAW_FILE_NAME=Area_QE_2018_Q2_0887_Sample_raw_F16_;Area_QE_2018_Q2_0986_Sample_raw_F16_
SUBJECT_SAMPLE_FACTORS           	-	FH4_4	Sex:Female | Timepoint:4	RAW_FILE_NAME=Area_QE_2018_Q2_0888_Sample_raw_F17_;Area_QE_2018_Q2_0987_Sample_raw_F17_
SUBJECT_SAMPLE_FACTORS           	-	FH4_1	Sex:Female | Timepoint:1	RAW_FILE_NAME=Area_QE_2018_Q2_0889_Sample_raw_F18_;Area_QE_2018_Q2_0988_Sample_raw_F18_
SUBJECT_SAMPLE_FACTORS           	-	FH4_3	Sex:Female | Timepoint:3	RAW_FILE_NAME=Area_QE_2018_Q2_0890_Sample_raw_F19_;Area_QE_2018_Q2_0989_Sample_raw_F19_
SUBJECT_SAMPLE_FACTORS           	-	QC12	Sex:- | Timepoint:-	RAW_FILE_NAME=Area_QE_2018_Q2_0891_QC_raw_F20_;Area_QE_2018_Q2_0990_QC_raw_F20_
SUBJECT_SAMPLE_FACTORS           	-	FH5_3	Sex:Female | Timepoint:3	RAW_FILE_NAME=Area_QE_2018_Q2_0892_Sample_raw_F21_;Area_QE_2018_Q2_0991_Sample_raw_F21_
SUBJECT_SAMPLE_FACTORS           	-	FH5_2	Sex:Female | Timepoint:2	RAW_FILE_NAME=Area_QE_2018_Q2_0893_Sample_raw_F22_;Area_QE_2018_Q2_0992_Sample_raw_F22_
SUBJECT_SAMPLE_FACTORS           	-	FH5_1	Sex:Female | Timepoint:1	RAW_FILE_NAME=Area_QE_2018_Q2_0894_Sample_raw_F23_;Area_QE_2018_Q2_0993_Sample_raw_F23_
SUBJECT_SAMPLE_FACTORS           	-	FH5_4	Sex:Female | Timepoint:4	RAW_FILE_NAME=Area_QE_2018_Q2_0895_Sample_raw_F24_;Area_QE_2018_Q2_0994_Sample_raw_F24_
SUBJECT_SAMPLE_FACTORS           	-	MH1_4	Sex:Male | Timepoint:4	RAW_FILE_NAME=Area_QE_2018_Q2_0896_Sample_raw_F25_;Area_QE_2018_Q2_0995_Sample_raw_F25_
SUBJECT_SAMPLE_FACTORS           	-	MH1_3	Sex:Male | Timepoint:3	RAW_FILE_NAME=Area_QE_2018_Q2_0897_Sample_raw_F26_;Area_QE_2018_Q2_0996_Sample_raw_F26_
SUBJECT_SAMPLE_FACTORS           	-	MH1_2	Sex:Male | Timepoint:2	RAW_FILE_NAME=Area_QE_2018_Q2_0898_Sample_raw_F27_;Area_QE_2018_Q2_0997_Sample_raw_F27_
SUBJECT_SAMPLE_FACTORS           	-	MH1_1	Sex:Male | Timepoint:1	RAW_FILE_NAME=Area_QE_2018_Q2_0899_Sample_raw_F28_;Area_QE_2018_Q2_0998_Sample_raw_F28_
SUBJECT_SAMPLE_FACTORS           	-	QC13	Sex:- | Timepoint:-	RAW_FILE_NAME=Area_QE_2018_Q2_0900_QC_raw_F29_;Area_QE_2018_Q2_0999_QC_raw_F29_
SUBJECT_SAMPLE_FACTORS           	-	MH2_4	Sex:Male | Timepoint:4	RAW_FILE_NAME=Area_QE_2018_Q2_0901_Sample_raw_F30_;Area_QE_2018_Q2_1000_Sample_raw_F30_
SUBJECT_SAMPLE_FACTORS           	-	MH2_3	Sex:Male | Timepoint:3	RAW_FILE_NAME=Area_QE_2018_Q2_0902_Sample_raw_F31_;Area_QE_2018_Q2_1001_Sample_raw_F31_
SUBJECT_SAMPLE_FACTORS           	-	MH2_1	Sex:Male | Timepoint:1	RAW_FILE_NAME=Area_QE_2018_Q2_0903_Sample_raw_F32_;Area_QE_2018_Q2_1002_Sample_raw_F32_
SUBJECT_SAMPLE_FACTORS           	-	MH2_2	Sex:Male | Timepoint:2	RAW_FILE_NAME=Area_QE_2018_Q2_0904_Sample_raw_F33_;Area_QE_2018_Q2_1003_Sample_raw_F33_
SUBJECT_SAMPLE_FACTORS           	-	MH3_4	Sex:Male | Timepoint:4	RAW_FILE_NAME=Area_QE_2018_Q2_0905_Sample_raw_F34_;Area_QE_2018_Q2_1004_Sample_raw_F34_
SUBJECT_SAMPLE_FACTORS           	-	MH3_3	Sex:Male | Timepoint:3	RAW_FILE_NAME=Area_QE_2018_Q2_0906_Sample_raw_F35_;Area_QE_2018_Q2_1005_Sample_raw_F35_
SUBJECT_SAMPLE_FACTORS           	-	MH3_2	Sex:Male | Timepoint:2	RAW_FILE_NAME=Area_QE_2018_Q2_0907_Sample_raw_F36_;Area_QE_2018_Q2_1006_Sample_raw_F36_
SUBJECT_SAMPLE_FACTORS           	-	MH3_1	Sex:Male | Timepoint:1	RAW_FILE_NAME=Area_QE_2018_Q2_0908_Sample_raw_F37_;Area_QE_2018_Q2_1007_Sample_raw_F37_
SUBJECT_SAMPLE_FACTORS           	-	QC14	Sex:- | Timepoint:-	RAW_FILE_NAME=Area_QE_2018_Q2_0909_QC_raw_F38_;Area_QE_2018_Q2_1008_QC_raw_F38_
SUBJECT_SAMPLE_FACTORS           	-	MH4_2	Sex:Male | Timepoint:2	RAW_FILE_NAME=Area_QE_2018_Q2_0910_Sample_raw_F39_;Area_QE_2018_Q2_1009_Sample_raw_F39_
SUBJECT_SAMPLE_FACTORS           	-	MH4_4	Sex:Male | Timepoint:4	RAW_FILE_NAME=Area_QE_2018_Q2_0911_Sample_raw_F40_;Area_QE_2018_Q2_1010_Sample_raw_F40_
SUBJECT_SAMPLE_FACTORS           	-	MH4_1	Sex:Male | Timepoint:1	RAW_FILE_NAME=Area_QE_2018_Q2_0912_Sample_raw_F41_;Area_QE_2018_Q2_1011_Sample_raw_F41_
SUBJECT_SAMPLE_FACTORS           	-	MH4_3	Sex:Male | Timepoint:3	RAW_FILE_NAME=Area_QE_2018_Q2_0913_Sample_raw_F42_;Area_QE_2018_Q2_1012_Sample_raw_F42_
SUBJECT_SAMPLE_FACTORS           	-	MH5_3	Sex:Male | Timepoint:3	RAW_FILE_NAME=Area_QE_2018_Q2_0914_Sample_raw_F43_;Area_QE_2018_Q2_1013_Sample_raw_F43_
SUBJECT_SAMPLE_FACTORS           	-	MH5_4	Sex:Male | Timepoint:4	RAW_FILE_NAME=Area_QE_2018_Q2_0915_Sample_raw_F44_;Area_QE_2018_Q2_1014_Sample_raw_F44_
SUBJECT_SAMPLE_FACTORS           	-	MH5_1	Sex:Male | Timepoint:1	RAW_FILE_NAME=Area_QE_2018_Q2_0916_Sample_raw_F45_;Area_QE_2018_Q2_1015_Sample_raw_F45_
SUBJECT_SAMPLE_FACTORS           	-	MH5_2	Sex:Male | Timepoint:2	RAW_FILE_NAME=Area_QE_2018_Q2_0917_Sample_raw_F46_;Area_QE_2018_Q2_1016_Sample_raw_F46_
SUBJECT_SAMPLE_FACTORS           	-	QC15	Sex:- | Timepoint:-	RAW_FILE_NAME=Area_QE_2018_Q2_0918_QC_raw_F47_;Area_QE_2018_Q2_1017_QC_raw_F47_
#COLLECTION
CO:COLLECTION_SUMMARY            	All haemolymph collections for all animals occurred at the same time of day and
CO:COLLECTION_SUMMARY            	the animals were handled in the same order on each of the four collection dates.
CO:COLLECTION_SUMMARY            	Haemolymph (200mL) was extracted from the ventral sinus of each crayfish using a
CO:COLLECTION_SUMMARY            	21G needle and 1mL syringe inserted into the soft tissue at the base of the 5th
CO:COLLECTION_SUMMARY            	pereopod. Haemolymph was added to 2mL Eppendorf tubes preloaded with 600µL
CO:COLLECTION_SUMMARY            	LC-MS grade acetonitrile (Optima, Thermo Fisher Scientific, AUS) containing
CO:COLLECTION_SUMMARY            	deuterated internal standards (d8- valine, d9 –trimethylamine-N-oxide (TMAO) ,
CO:COLLECTION_SUMMARY            	d3-leucine, d6-trans-cinnamic acid, d5-tryptophan, 1g/mL) from Cambridge
CO:COLLECTION_SUMMARY            	Isotope Laboratories (Cambridge, MA, USA) and stored on ice. Samples were mixed
CO:COLLECTION_SUMMARY            	at 1400rpm (Thermal Mixer, Thermo Fisher Scientific, AUS) for 60 seconds at
CO:COLLECTION_SUMMARY            	4°C, then centrifuged (Heraeus Megafuge 8R, Thermo Fisher Scientific, AUS) for
CO:COLLECTION_SUMMARY            	20 minutes (1800  g) at 4°C. After centrifuging, 100µL of supernatant was
CO:COLLECTION_SUMMARY            	aliquoted into five separate vials. The samples were then dried using a
CO:COLLECTION_SUMMARY            	SpeedVac centrifugal vacuum concentrator (Thermo Fisher Scientific, AUS). The
CO:COLLECTION_SUMMARY            	dried samples were stored at -80°C for subsequent metabolomics analysis.
CO:COLLECTION_PROTOCOL_FILENAME  	EmilyLette_20210225_014138_PR_CO_Methods__Lette_marron.pdf
CO:SAMPLE_TYPE                   	Hemolymph
CO:COLLECTION_METHOD             	aspiration
CO:COLLECTION_LOCATION           	ventral sinus accessed from soft tissue at base of 5th pereopod
CO:STORAGE_CONDITIONS            	-80℃
CO:COLLECTION_VIALS              	2mL Eppendorf tubes
CO:STORAGE_VIALS                 	2mL Eppendorf tubes
#TREATMENT
TR:TREATMENT_SUMMARY             	Cherax tenuimanus (n=10) were housed in aquaria as individuals prior to sampling
TR:TREATMENT_SUMMARY             	at timepoint 1. After timepoint 1 they were placed in pairs with a potential
TR:TREATMENT_SUMMARY             	mate of the opposite sex and housed in aquaria over the next four weeks which
TR:TREATMENT_SUMMARY             	included timepoints 2-4.
#SAMPLEPREP
SP:SAMPLEPREP_SUMMARY            	The dried haemolymph samples were reconstituted using 100µL of LC-MS water
SP:SAMPLEPREP_SUMMARY            	containing 0.1% Formic acid. Samples were manually swirled, then placed in a
SP:SAMPLEPREP_SUMMARY            	thermomixer for 2 minutes at 4oC, before being centrifuged at (1800  g) for 5
SP:SAMPLEPREP_SUMMARY            	minutes at 4oC. Next, 40µL of the supernatant was transferred into LC-MS amber
SP:SAMPLEPREP_SUMMARY            	vials with inserts and placed in the autosampler kept at 6oC. The order in which
SP:SAMPLEPREP_SUMMARY            	samples were analysed was randomised to avoid any potential instrument bias. A
SP:SAMPLEPREP_SUMMARY            	pooled quality control (QC) sample was prepared by adding 40 µL from each
SP:SAMPLEPREP_SUMMARY            	reconstituted sample to a single Eppendorf tube, which was then mixed to
SP:SAMPLEPREP_SUMMARY            	homogenise in a thermal mixer and centrifuged as above. This pooled sample was
SP:SAMPLEPREP_SUMMARY            	aliquoted (40µL) into LC-MS amber vials to create 16 QC samples and placed into
SP:SAMPLEPREP_SUMMARY            	the autosampler tray kept at 6°C ready for analysis. Samples were analysed
SP:SAMPLEPREP_SUMMARY            	within 24 hours from preparation. At the start of the analytical batch, a
SP:SAMPLEPREP_SUMMARY            	solvent blank, matrix blank, and ten conditioning QC samples were analysed
SP:SAMPLEPREP_SUMMARY            	(Broadhurst et al., 2018). QC samples were then injected after every fifth
SP:SAMPLEPREP_SUMMARY            	marron haemolymph sample with two QCs analysed at the end of the batch,
SP:SAMPLEPREP_SUMMARY            	following the standard protocols for metabolomics (Broadhurst et al., 2018).
SP:PROCESSING_STORAGE_CONDITIONS 	Described in summary
#CHROMATOGRAPHY
CH:CHROMATOGRAPHY_TYPE           	Reversed phase
CH:INSTRUMENT_NAME               	Thermo Dionex Ultimate 3000 RS
CH:COLUMN_NAME                   	Thermo Hypersil GOLD C18 (100 x 2.1mm,1.9µm)
CH:FLOW_GRADIENT                 	isocratic at 99% A: 1 min; 50% B:1-2 min; linear increase to 99% B: over 7min;
CH:FLOW_GRADIENT                 	99% B: 2min; initial conditions returned over 2 min; 100% A: 3 min.
CH:FLOW_RATE                     	0.3mL/min
CH:COLUMN_TEMPERATURE            	45
CH:METHODS_FILENAME              	Methods_Lette_marron
CH:SOLVENT_A                     	0.1% formic acid in LC-MS water
CH:SOLVENT_B                     	0.1% formic acid in LC-MS acetonitrile
#ANALYSIS
AN:ANALYSIS_TYPE                 	MS
#MS
MS:INSTRUMENT_NAME               	Thermo Q Exactive Orbitrap
MS:INSTRUMENT_TYPE               	Orbitrap
MS:MS_TYPE                       	ESI
MS:ION_MODE                      	NEGATIVE
MS:MS_COMMENTS                   	Full scans with data-dependent tandem mass spectrometry were acquired on the
MS:MS_COMMENTS                   	Orbitrap mass analyzer. Full scans were acquired at a resolution of 70,000 at
MS:MS_COMMENTS                   	mass-to-charge ratio (m/z) 200 over the m/z range 70–1000 with the ESI
MS:MS_COMMENTS                   	conditions as follows: source heater = 350°C, sheath gas = 35 (arbitrary
MS:MS_COMMENTS                   	units), auxiliary gas = 10 (arbitrary units), capillary temperature 350°C, ion
MS:MS_COMMENTS                   	spray voltage = 3.0 kV (positive ion mode) and 2.5 kV (negative ion mode),
MS:MS_COMMENTS                   	S-lens 50%, and automatic gain control = 110¬¬¬-6. Tandem mass
MS:MS_COMMENTS                   	spectrometry experiments were performed at a resolution of 17,500 at m/z 200 on
MS:MS_COMMENTS                   	each sample with the higher energy collisional dissociation energy set at 20 eV.
MS:MS_COMMENTS                   	Data acquisition was carried out using Xcalibur software (Thermo Fisher
MS:MS_COMMENTS                   	Scientific). Before analysis, the Orbitrap was externally calibrated using
MS:MS_COMMENTS                   	ready-made calibration solutions (ESI-negative ion calibration and ESI-positive
MS:MS_COMMENTS                   	ion calibration solutions) obtained from Thermo Fisher Scientific.
#MS_METABOLITE_DATA
MS_METABOLITE_DATA:UNITS	peak area values
MS_METABOLITE_DATA_START
Samples	FH1_4	FH1_2	FH1_3	FH1_1	FH2_1	FH2_3	FH2_2	FH2_4	FH3_3	FH3_1	FH3_2	FH3_4	FH4_2	FH4_4	FH4_1	FH4_3	FH5_3	FH5_2	FH5_1	FH5_4	MH1_4	MH1_3	MH1_2	MH1_1	MH2_4	MH2_3	MH2_1	MH2_2	MH3_4	MH3_3	MH3_2	MH3_1	MH4_2	MH4_4	MH4_1	MH4_3	MH5_3	MH5_4	MH5_1	MH5_2
Factors	Sex:Female | Timepoint:4	Sex:Female | Timepoint:2	Sex:Female | Timepoint:3	Sex:Female | Timepoint:1	Sex:Female | Timepoint:1	Sex:Female | Timepoint:3	Sex:Female | Timepoint:2	Sex:Female | Timepoint:4	Sex:Female | Timepoint:3	Sex:Female | Timepoint:1	Sex:Female | Timepoint:2	Sex:Female | Timepoint:4	Sex:Female | Timepoint:2	Sex:Female | Timepoint:4	Sex:Female | Timepoint:1	Sex:Female | Timepoint:3	Sex:Female | Timepoint:3	Sex:Female | Timepoint:2	Sex:Female | Timepoint:1	Sex:Female | Timepoint:4	Sex:Male | Timepoint:4	Sex:Male | Timepoint:3	Sex:Male | Timepoint:2	Sex:Male | Timepoint:1	Sex:Male | Timepoint:4	Sex:Male | Timepoint:3	Sex:Male | Timepoint:1	Sex:Male | Timepoint:2	Sex:Male | Timepoint:4	Sex:Male | Timepoint:3	Sex:Male | Timepoint:2	Sex:Male | Timepoint:1	Sex:Male | Timepoint:2	Sex:Male | Timepoint:4	Sex:Male | Timepoint:1	Sex:Male | Timepoint:3	Sex:Male | Timepoint:3	Sex:Male | Timepoint:4	Sex:Male | Timepoint:1	Sex:Male | Timepoint:2
Uridine-5'-phosphoric acid disodium salt	31904.42859	177303.5079	26361.21716	336286.9114	284496.3138	51048.16339	46580.30549	544304.5351	40708.82587	276840.9992	60211.92045	178431.8637	80265.81777	123087.904	662435.2612	61917.42375	32907.76447	84462.2479	52855.27723	126758.6482	120473.5737	32011.254	71792.17373	51506.75842	47830.67427	14942.65662	19903.12391	35811.06605	39232.92642	5912.837354	169170.8346	49497.26362	688093.1342	151691.9516	22169.70851	107096.3726	33102.1552	287940.4999	9056.474022	52546.81216
Sucrose	70542.41055	72891.59562	69522.03939	52707.02607	117908.4841	73839.19037	99984.1763	39624.85158	13019.74452	100574.1753	94619.24022	33875.56939	60536.05699	47711.80617	113732.0642	60697.18232	29543.3592	179457.6336	97747.55846	21999.78918	85905.62826	107926.0567	87487.0463	135799.9351	83096.99953	53168.3698	142680.7573	88442.02317	29795.0413	11639.84466	3064659.87	231467.5968	52908.12418	31299.65072	49445.3477	38308.05557	12946.44137	28787.55149	302144.9727	74325.7096
Azelaic acid	1395797.305	9657471.261	1260963.175	5336086.544	12724355.41	1511973.787	5195489.553	1292388.105	1419078.654	10010106.17	4646533.428	1256484.845	5496863.146	1260821.045	24631277.86	1230609.482	1199759.247	5129309.61	5680334.324	1275736.018	1963290.962	1154036.585	4485841.111	8456793.791	1197521.237	1231666.377	9671545.192	5643126.422	1367300.45	1691146.148	10210249.18	13525880.18	20449485.37	1231364.265	3465165.3	1472379.862	1226012.694	1327562.092	9564634.412	4531201.482
Kynurenic acid	1412.649885	67879.04057	42307.0614	272875.6308	7839.562664	62413.53934	9306.409631	220382.7761	31153.09686	81662.74444	43405.68369	40690.18242	39589.20033	20068.79426	283518.1989	24734.42336	54130.30884	54399.19579	59549.30683	50601.61359	1763.659907	1000.168875	1198.857694	1092.478308	1113.985072	787.9857902	1223.943601	1592.868276	900.0751328	694.571393	1197.643463	2128.592862	1792.734393	1202.888475	933.8487814	1199.962065	1370.800498	2585.273247	998.5005161	1197.629382
Inosine	4445794.114	5823097.752	5061786.269	5553904.456	3710286.25	1632924.827	2367736.45	5964960.003	4730225.797	8876111.812	7225637.319	2529044.777	3431409.099	3541887.147	5690405.792	4291729.281	5000151.457	6447830.914	8052726.657	2956817.552	2860025.839	2152064.282	1945883.103	1231189.449	1409277.907	1567598.787	2160913.256	1317561.472	1316459.112	1997641.309	2532323.794	3215983.233	2403431.529	2291247.745	862715.3885	1601828.579	1551048.869	2045035.43	1676359.296	1439277.279
Deoxyinosine	29229.02048	51230.64886	45241.78978	69351.97166	61521.9116	62539.63569	65434.21054	89601.39565	34051.2439	46692.15091	39368.66988	36596.74328	33147.94788	32506.14178	68765.78043	34613.15241	43911.88485	45262.0752	49850.34782	45079.34136	26722.3581	27247.02534	23116.93987	183.3640152	22070.21044	44099.40894	233.1306524	32757.47376	24495.9952	37094.32092	44549.79035	6790.274531	40795.0211	39364.82842	38127.51102	91721.51013	67568.03704	39148.83608	434.3411672	76374.87543
Indolelactic acid	2506215.587	2303722.732	2371394.091	1124355.246	369964.2857	2222437.128	546768.2139	1850711.828	1997955.966	1074470.967	1775494.707	2939394.652	863910.9982	2108745.809	1278282.679	2003567.991	1832008.777	1831705.102	2071040.752	4075723.858	899603.357	784418.8431	1317098.753	333647.2487	1376940.865	1863025.278	785081.7371	1677802.5	895202.2405	1272460.452	1889425.399	1312825.017	3933571.725	1307195.794	1192497.858	2765298.783	2576262.229	1467643.574	761208.7291	3535838.386
Hydroxyphenyllactic acid	1055532.868	174708.8859	200822.9535	59940.2396	35152.10484	120422.3165	55979.84566	114395.4999	144434.0706	75803.00979	232544.2316	169294.6597	103849.5311	161351.2396	119515.411	119517.8161	135786.0778	125401.1642	77229.11595	196957.2466	141763.4975	92751.86393	114146.8743	70307.01072	100948.4531	83659.69385	74481.96498	94987.34734	69150.77051	71469.6286	96744.15568	60041.02824	95319.61365	276178.8398	32995.21649	139214.3342	93950.90583	114245.1463	108873.3111	109155.9165
Glutathione	1628.986326	8756.251135	1101.62743	1353.975015	10831.91156	758.5223982	3029.16889	1694.53477	10463.55038	1389.875999	3394.757056	8523.716705	1757.318208	1205.698405	15624.07122	909.1266002	864.5271025	2047.262666	16824.81048	96761.46405	1366.563527	785.3244392	2425.216067	693.4328332	31012.58036	702.6894447	14797.8397	17186.72603	4643.117283	727.5474882	1380.294491	13734.22742	1854.450862	1665.762191	839.9984648	5606.112815	2165.93514	3112.187641	973.3094181	7071.705797
Oxidized glutathione	8519.589502	115317.7517	19442.54602	120329.0035	127249.7395	38467.46771	53903.31594	747685.8613	17710.04164	86061.93716	17288.98418	111399.5792	63966.66636	183050.4377	381011.1918	53811.05015	12141.55057	68211.94773	5834.710867	98526.98655	224228.7786	26262.09787	56735.5731	112181.1129	27556.11734	5630.204428	99224.27724	12898.11819	8601.571482	2406.017304	118880.2286	206477.9062	890220.9019	139121.9363	6812.365099	65072.33191	25564.84753	277411.4022	139356.5346	46635.59505
Uridine	10730038.63	21874090.18	19678525.19	24904847.2	24221557.88	21090186.39	26799358.24	21769387.57	22935620.15	32561970.07	32443012.8	16631237.68	17142485.15	19272245.66	26476685.59	19253457.93	19526136.2	21276543.21	28529021.76	13967570.83	22704421.87	24155295	23151974.46	25714817.68	21454870.6	23473747.34	26263471.98	24078097.86	17154869.51	22414933.35	24395115.39	25740362.49	22582782.13	21705807.11	11222104.77	22470688.34	19889693.83	19298681.48	18961019.63	19260514.88
Tryptophan	70751.49963	132771.0561	119605.1682	172242.3194	179166.0394	109287.0062	149196.9799	93741.15531	124074.7239	116444.608	138680.0307	102241.5253	75308.34176	91824.42466	153989.4586	87095.70428	137005.4642	176239.1651	129331.9207	157648.3429	58074.37582	70469.44486	70766.73397	38016.62349	81449.1882	115532.6712	64449.5441	111109.6489	101722.9574	121071.5028	158625.3789	85257.11796	113136.7688	74032.37438	86119.10493	121025.6495	124131.9781	84658.65044	31419.11163	138633.5929
Pantothenic acid	7766977.348	222590.7265	159356.0732	440156.9869	394466.4805	97573.13457	90666.92641	165719.5249	132541.5686	366328.8019	167159.5079	101483.5044	116037.7544	184613.676	667947.6509	169517.4988	96878.62457	179077.2661	204277.1199	120529.842	132378.6966	74537.32322	63373.1696	149714.1454	69812.6577	60493.98985	192640.751	90050.1821	68362.48234	86152.31147	149777.6336	391808.6267	517797.5831	148780.2037	68228.14134	169089.9593	68934.27276	145959.0208	640716.5235	118502.5943
Citric acid	547720.8911	224977.9216	52242.06618	749659.0696	365190.0129	30394.43001	33725.66684	674937.402	60277.49188	405615.6623	148952.8901	104382.1512	77900.1136	258485.4333	563246.5728	58598.94747	27328.85698	607672.7408	66647.55593	120024.2698	1065159.625	212602.6602	131062.6229	325342.8637	53977.34512	11629.62069	220883.9055	52817.96656	31945.83544	15970.55784	258518.1156	322441.747	1152583.826	298013.909	18289.47868	195710.9815	26087.91456	200392.5479	157766.1975	102598.9385
MS_METABOLITE_DATA_END
#METABOLITES
METABOLITES_START
metabolite_name	KEGG ID	PubChem ID	Formula	Retention time	MW
Uridine-5'-phosphoric acid disodium salt	C00105	6030	C9 H13 N2 O9 P	0.951	324.03573
Sucrose	C00089	5988	C12 H22 O11	0.945	342.1158
Azelaic acid	C08261	2266	C9 H16 O4	3.736	188.10403
Kynurenic acid	C01717	3845	C10 H7 N O3	3.223	189.04183
Inosine	C00294	6021	C10 H12 N4 O5	2.252	268.08085
Deoxyinosine	C05512	65058	C10 H12 N4 O4	2.758	252.08565
Indolelactic acid	C02043	676157	C11 H11 N O3	3.674	205.07327
Hydroxyphenyllactic acid	C03672	9378	C9 H10 O4	3.188	182.05708
Glutathione	C00051	124886	C10 H17 N3 O6 S	1.287	307.08369
Oxidized glutathione	C00127	65359	C20 H32 N6 O12 S2	1.624	612.15131
Uridine	C00299	6029	C9 H12 N2 O6	1.541	244.06926
Tryptophan	C00078	6305	C11 H12 N2 O2	3.189	204.08927
Pantothenic acid	C00864	6613	C9 H17 N O5	3.045	219.11021
Citric acid	C00158	311	C6 H8 O7	1.289	192.02613
METABOLITES_END
#END